4.8 Article

ATR-Mediated Global Fork Slowing and Reversal Assist Fork Traverse and Prevent Chromosomal Breakage at DNA Interstrand Cross-Links

Journal

CELL REPORTS
Volume 24, Issue 10, Pages 2629-+

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2018.08.019

Keywords

-

Categories

Funding

  1. SNF [31003A_169959, PP00P2_133568, PP00P2_157545]
  2. ERC Consolidator Grant [617102]
  3. ERC Consolidator Grant PhotoMedMet [GA 681679]
  4. University of Zurich
  5. program Investissements d'Avenir [ANR-10-IDEX-0001-02 PSL]
  6. European Union's Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Grant) [704817]
  7. European Research Council (ERC) [617102] Funding Source: European Research Council (ERC)
  8. Marie Curie Actions (MSCA) [704817] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

Interstrand cross-links (ICLs) are toxic DNA lesions interfering with DNA metabolism that are induced by widely used anticancer drugs. They have long been considered absolute roadblocks for replication forks, implicating complex DNA repair processes at stalled or converging replication forks. Recent evidence challenged this view, proposing that single forks traverse ICLs by yet elusive mechanisms. Combining ICL immunolabeling and single-molecule approaches in human cells, we now show that ICL induction leads to global replication fork slowing, involving forks not directly challenged by ICLs. Active fork slowing is linked to rapid recruitment of RAD51 to replicating chromatin and to RAD51/ZRANB3-mediated fork reversal. This global modulation of fork speed and architecture requires ATR activation, promotes single-fork ICL traverse-here, directly visualized by electron microscopy-and prevents chromosomal breakage by untimely ICL processing. We propose that global fork slowing by remodeling provides more time for template repair and promotes bypass of residual lesions, limiting fork-associated processing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available